Ingevity Corporation NGVT
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.16B | 1.18B | 1.17B | 1.18B | 1.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.16B | 1.18B | 1.17B | 1.18B | 1.18B |
| Cost of Revenue | 683.20M | 711.80M | 706.20M | 702.30M | 705.30M |
| Gross Profit | 477.10M | 465.90M | 461.40M | 473.60M | 471.30M |
| SG&A Expenses | 165.40M | 170.00M | 171.20M | 167.90M | 161.70M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 875.80M | 909.90M | 905.80M | 897.80M | 893.80M |
| Operating Income | 284.50M | 267.80M | 261.80M | 278.10M | 282.80M |
| Income Before Tax | 37.80M | -149.50M | -142.10M | -12.70M | -20.90M |
| Income Tax Expenses | 12.60M | 6.50M | 8.20M | 39.30M | 24.40M |
| Earnings from Continuing Operations | 25.20 | -156.00 | -150.30 | -52.00 | -45.30 |
| Earnings from Discontinued Operations | 28.80M | 28.20M | -16.80M | -13.90M | -171.30M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.00M | -127.80M | -167.10M | -65.90M | -216.60M |
| EBIT | 284.50M | 267.80M | 261.80M | 278.10M | 282.80M |
| EBITDA | 380.20M | 368.20M | 365.70M | 393.40M | 398.70M |
| EPS Basic | 1.54 | -3.49 | -4.62 | -1.79 | -5.94 |
| Normalized Basic EPS | 3.51 | 2.14 | 1.93 | 1.81 | 1.83 |
| EPS Diluted | 1.46 | -3.55 | -4.66 | -1.83 | -5.95 |
| Normalized Diluted EPS | 3.45 | 2.11 | 1.91 | 1.79 | 1.82 |
| Average Basic Shares Outstanding | 141.96M | 143.77M | 144.89M | 145.49M | 145.53M |
| Average Diluted Shares Outstanding | 143.95M | 145.17M | 145.82M | 146.72M | 146.26M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |